PERKINS CAPITAL MANAGEMENT INC - Q3 2017 holdings

$95.4 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 101 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 72.2% .

 Value Shares↓ Weighting
ABT BuyABBOTT LABS$4,432,000
+10.2%
83,060
+0.4%
4.64%
+4.1%
VCEL BuyVERICEL CORP$3,376,000
+297.2%
562,600
+118.4%
3.54%
+275.1%
BVX BuyBOVIE MEDICAL CORP$2,108,000
+42.2%
623,685
+4.0%
2.21%
+34.4%
APPS BuyDIGITAL TURBINE INC$1,376,000
+54.8%
911,080
+5.5%
1.44%
+46.2%
AFL BuyAFLAC INC$1,257,000
+5.7%
15,450
+1.0%
1.32%
-0.2%
ATRS BuyANTARES PHARMA INC$1,186,000
+3606.2%
366,000
+3560.0%
1.24%
+3451.4%
CVS BuyCVS HEALTH CORP$1,155,000
+2.2%
14,200
+1.1%
1.21%
-3.4%
BMY NewBRISTOL MYERS SQUIBB CO$1,117,00017,525
+100.0%
1.17%
PFIE BuyPROFIRE ENERGY INC$1,048,000
+53.4%
526,481
+0.2%
1.10%
+45.0%
ABC BuyAMERISOURCEBERGEN CORP$976,000
-0.7%
11,800
+13.5%
1.02%
-6.1%
PNR BuyPENTAIR PLC$962,000
+21.0%
14,150
+18.4%
1.01%
+14.3%
USAT BuyUSA TECHNOLOGIES INC$693,000
+22.4%
110,850
+1.8%
0.73%
+15.6%
ATHX NewATHERSYS INC$636,000308,725
+100.0%
0.67%
VCYT NewVERACYTE INC$546,00062,275
+100.0%
0.57%
HEAR BuyTURTLE BEACH CORP$520,000
+41.3%
626,359
+19.0%
0.54%
+33.6%
CDNA NewCAREDX INC$513,000138,550
+100.0%
0.54%
OPGN NewOPGEN INC$434,0001,400,000
+100.0%
0.46%
CY BuyCYPRESS SEMICONDUCTOR CORP$430,000
+13.2%
28,625
+2.7%
0.45%
+7.1%
IONS BuyIONIS PHARMACEUTICALS INC$418,000
+3.5%
8,250
+3.8%
0.44%
-2.2%
CYTX BuyCYTORI THERAPEUTICS INC$335,000
-65.2%
912,995
+4.4%
0.35%
-67.1%
BKYI NewBIO-KEY INTERNATIONAL INC$265,00092,420
+100.0%
0.28%
CTG BuyCOMPUTER TASK GROUP INC$244,000
-0.4%
45,500
+3.9%
0.26%
-5.9%
AMD NewADVANCED MICRO DEVICES INC$223,00017,500
+100.0%
0.23%
FEYE NewFIREEYE INC$214,00012,735
+100.0%
0.22%
BSX NewBOSTON SCIENTIFIC CORP$204,0007,000
+100.0%
0.21%
AMRN BuyAMARIN CORP PLCspons adr new$174,000
+4.2%
49,600
+19.5%
0.18%
-1.6%
REI NewRING ENERGY INC$145,00010,000
+100.0%
0.15%
YUMA NewYUMA ENERGY INC NEW$143,000150,000
+100.0%
0.15%
GWGH NewGWG HLDGS INC$105,00010,400
+100.0%
0.11%
BLFS BuyBIOLIFE SOLUTIONS INC$86,000
+258.3%
15,000
+50.0%
0.09%
+233.3%
CHFS NewCHF SOLUTIONS INC$59,000100,000
+100.0%
0.06%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-10-31
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEOGENOMICS INC41Q3 20237.8%
LILY ELI & CO41Q3 20236.9%
PFIZER INC41Q3 20232.9%
ATTUNITY LTD41Q3 20233.6%
EXPEDITORS INTL WASH INC41Q3 20232.3%
CVS HEALTH CORP41Q3 20231.6%
DONALDSON INC41Q3 20231.3%
VERIZON COMMUNICATIONS INC41Q3 20231.0%
US BANCORP DEL41Q3 20230.8%
BAXTER INTL INC40Q3 202314.1%

View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
PERKINS CAPITAL MANAGEMENT INC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BIOLASE, INCMay 15, 2023689,1962.1%
FlexShopper, Inc.February 09, 20231,281,4605.9%
Avinger IncFebruary 14, 2020891,7615.2%
Black Ridge Oil & Gas, Inc.February 15, 201930,021,0326.3%
CANCER GENETICS, INCFebruary 15, 20191,135,2504.0%
TearLab CorpFebruary 15, 20191,666,29413.1%
Xtant Medical Holdings, Inc.February 15, 2019684,4083.6%
TearLab CorpJanuary 26, 20184,300,65540.1%
BIO KEY INTERNATIONAL INCFebruary 09, 2017274,9004.4%
EnteroMedics IncFebruary 09, 20171,4550.0%

View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-01-22
13F-HR2023-11-02
13F-HR2023-07-21
SC 13G/A2023-05-15
13F-HR2023-05-09
SC 13G/A2023-02-09
SC 13G2023-02-09
13F-HR2023-01-26
13F-HR2022-10-24
13F-HR2022-07-29

View PERKINS CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported number of holdings is incorrect (101 != 102)

Export PERKINS CAPITAL MANAGEMENT INC's holdings